Medicine
Showing 851-900 of 2,424 Results
-
Stephanie Hsiao, MD
Clinical Assistant Professor, Medicine - Cardiovascular Medicine
BioDr. Stephanie Hsiao is a clinical assistant professor at Stanford Medicine and a full-time advanced heart failure/transplant cardiologist at the Palo Alto VA. She is the associate program director of the Stanford Cardiology Fellowship and the site director of Palo Alto VA. She grew up in Taipei, Taiwan. She attended undergraduate at UC Berkeley and obtained her Master’s degree in Pharmacology at Cambridge University in the UK. She obtained her M.D. from UC San Francisco. She completed her Internal Medicine residency and General Cardiology fellowship at the California Pacific Medical Center in San Francisco, where she served as the chief resident and chief cardiology fellow. She completed her advanced heart failure/transplant cardiology fellowship at Stanford in June 2022 and joined the Stanford Faculty soon after. She has a strong interest in medical education and quality improvement. Her clinical interests include HF outreach in the VA health care systems, cardiology fellowship curriculum design/development and humanism in medicine. Her research interests include multi-organ transplantations, advanced HF therapies for the underserved and CardioPalliative integration. She plans to lead a career in medical education and quality improvement to deliver exceptional and equitable care for patients needing advanced HF therapies.
-
Robert Hsieh
Adjunct Clinical Assistant Professor, Medicine - Oncology
BioRobert W. Hsieh, M.D. Ph.D. is a medical oncologist who specializes in the treatment of prostate cancer, bladder cancer, kidney (renal) cancer and testicular cancer as a member of Stanford's multi-disciplinary Urologic Cancer Program. Dr. Hsieh obtained his M.D. and Ph.D. degrees at the University of Chicago (Pritzker School of Medicine) and subsequently came to Stanford to complete his Internal Medicine residency and Hematology and Oncology fellowship training (with a clinical focus on genitourinary cancers).
Dr. Hsieh has also had extensive experience in basic lab research (cancer stem cells, target identification and validation, pre-clinical drug discovery) having done post-doctoral work in the Clarke Lab in the Institute for Stem Cell Biology and Regenerative Medicine. He is currently involved in early phase clinical trials in immuno-oncology in industry. -
Gary Hsin
Clinical Professor (Affiliated), Medicine - Primary Care and Population Health
Staff, Medicine - Primary Care and Population HealthBioGary Hsin, MD, is a Clinical Professor (Affiliated) and Chief of Palliative Medicine at the Veterans Affairs Palo Alto Health Care System. His academic and clinical interests include palliative care delivery and education, global health, and compassion cultivation.
Dr. Hsin earned his medical degree from the Northwestern University School of Medicine and completed his family medicine residency and chief residency at West Suburban Medical Center in Oak Park, Illinois. He subsequently completed fellowship training in Palliative Medicine at Massachusetts General Hospital through the Harvard Palliative Medicine Fellowship Program. He is also a certified Compassion Cultivation Training instructor through Stanford’s Center for Compassion and Altruism Research and Education (CCARE) and the Compassion Institute.
Dr. Hsin has been involved in global health initiatives across Africa and Asia with the Centers for Disease Control and Prevention (CDC), Doctors Without Borders (MSF), and the Stanford/Yale Global Health Scholars Program. He is a Faculty Fellow with Stanford’s Center for Innovation in Global Health. -
Ann Hsing
Professor (Research) of Medicine (Stanford Prevention Research Center/Cancer Institute) and of Epidemiology and Population Health
Current Research and Scholarly InterestsResearch Focus
• Epidemiology of prostate, hepatobiliary, and thyroid cancers
• Racial disparities in cancer
• Endogenous hormones/growth factors
• Circadian rhythms
• Chronic inflammation
• Genetic susceptibility
• Cancer prevention and control
• Global oncology and international studies -
Emory Hsu, M.D.
Clinical Assistant Professor (Affiliated), Medicine - Med/Endocrinology
Staff, Medicine - Med/EndocrinologyBioEmory Hsu received his Bachelor’s degree in Biochemical Sciences with honors from Harvard University. He then attended medical school at Vanderbilt University, during which he completed an extra research year fellowship through Howard Hughes Medical Institute and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) at the National Institutes of Health in Bethesda, Maryland. He then completed his internship and residency training in Internal Medicine - research track at Emory University, followed by a fellowship in Endocrinology, Lipids, and Metabolism there. He is board certified in both Internal Medicine and Endocrinology. He is actively involved in the teaching and training of Stanford University Endocrinology fellows, Internal Medicine residents, and medical students.
-
Joe Le Hsu
Assistant Professor of Medicine (Pulmonary and Critical Care)
Current Research and Scholarly InterestsI am interested in understanding the host-pathogen interaction between Aspergillus fumigatus and the lung transplant recipient.
-
Jiaqi Hu
Postdoctoral Scholar, Cardiovascular Medicine
BioJiaqi Hu is a Postdoctoral Scholar at Stanford University, supervised by Drs. Tim Assimes and Shoa Clarke. She received her PhD in Chronic Disease Epidemiology from the Yale School of Public Health in 2026 and her Bachelor of Arts degree from Peking University in 2021. Her research focuses on identifying genetic variants underlying complex diseases, applying polygenic scores for disease risk prediction and subtype identification, and integrating genetic, environmental, and clinical data to improve individual-level risk stratification.
-
Robert Huang
Assistant Professor of Medicine (Gastroenterology and Hepatology)
Current Research and Scholarly InterestsEpidemiology
Epidemiology of gastric cancer
Racial and ethnic disparities in gastric cancer
Gastric intestinal metaplasia and other precancerous lesions
Molecular marker development
Microbiome -
Michelle Huffaker, MD
Clinical Assistant Professor, Medicine - Pulmonary, Allergy & Critical Care Medicine
BioDr. Michelle Huffaker is a board-certified, fellowship-trained allergist and immunologist with Stanford Health Care. She is a clinical assistant professor in the Department of Medicine, Division of Pulmonary, Allergy, and Critical Care Medicine at Stanford University School of Medicine.
Dr. Huffaker specializes in diagnosing and treating allergies and health conditions that affect the immune system. She is particularly interested in asthma, food allergies, and allergic rhinitis.
Dr. Huffaker’s research is focused on treatments that achieve long-lasting remission for allergic and immunologic diseases, such as food allergies and allergic rhinitis. Dr. Huffaker is the director of clinical and translational medicine for the allergy portfolio of the Immune Tolerance Network (ITN), a clinical research consortium funded by the National Institute of Allergy and Infectious Diseases (NIAID). The ITN focuses on achieving immune tolerance in conditions where the body attacks healthy cells (immune-mediated diseases). Dr. Huffaker leads the development, conduct, and analysis of ITN clinical trials.
Dr. Huffaker has published her research in peer-reviewed journals, such as Allergy, The Journal of Allergy and Clinical Immunology, and World Allergy Organization Journal. She has presented to her peers at international, national, and regional meetings, including those of the European Academy of Allergy and Clinical Immunology (EAACI), the American Academy of Allergy, Asthma, and Immunology (AAAAI), and the American College of Allergy, Asthma, and Immunology (ACAAI).
Dr. Huffaker is a fellow of AAAAI and a member of AAAAI, EAACI, and the Western Society of Allergy, Asthma, and Immunology. -
William Hui, MD
Clinical Assistant Professor, Medicine - Primary Care and Population Health
BioDr. Hui is a family medicine physician. He practices in the Stanford Family Medicine clinic in Palo Alto and is a Clinical Assistant Professor in the Department of Medicine, Division of Primary Care and Population Health. He serves as the point-of-care ultrasound (POCUS) and Minor Procedure Service Director in the Division of Primary Care and Population Health.
Dr. Hui completed fellowship training in point-of-care ultrasound at the University of Pennsylvania. He trained as a resident in family medicine at Stanford Health Care - O'Connor Hospital after earning his medical degree at Drexel University College of Medicine.
He is interested in the utilization of point of care ultrasound in outpatient primary care.
Dr. Hui is a member of the American Academy of Family Physicians, American Institute of Ultrasound in Medicine, and Society of Teachers of Family Medicine.
Dr. Hui enjoys long-distance running and bouldering in his free time. He is also a coffee enthusiast.
He speaks English fluently and Cantonese with limited working proficiency. -
Sharon Wei Hung
Clinical Associate Professor, Medicine - Primary Care and Population Health
BioSharon Hung MD, FACP is a board-certified Internal Medicine physician practicing at the Stanford Internal Medicine Clinic in Santa Clara. She earned her MD from the Northwestern University Feinberg School of Medicine and completed her internal medicine residency at Cedars-Sinai Medical Center. Prior to joining Stanford, she served on the faculty at the University of Arizona College of Medicine.
Dr. Hung is the Director of Women’s Health for the Department of Primary Care and Population Health. In this role, she served as course director for Stanford CME’s Women’s Health Conference and continues to co-direct the annual Stanford CME Menopause and Healthy Aging Conference. She also hosts the Stanford CME/YouTube Women’s Health Vodcast, where she interviews leading experts and explores timely, clinically relevant topics in women’s health.
Her scholarly interests include breast cancer screening, steatotic liver disease, osteoporosis, and weight gain during the perimenopausal period. Clinically, she is dedicated to preventive medicine and the management of chronic conditions such as pre-diabetes, obesity and metabolic syndrome, as well as guiding women through the perimenopausal transition. Dr. Hung also leads bi-monthly group patient visits focused on the prevention and treatment of osteoporosis. She is passionate about inspiring trainees and works with both Stanford Internal Medicine residents and Physician Assistant students.
She is conversational in both Spanish and Mandarin. -
Jennifer L. Hunter, PA-C
Clinical Assistant Professor, Medicine - Primary Care and Population Health
BioJennifer Hunter, PA-C is the Lead Advanced Practice Provider (APP) for the Emergency Department & Clinical Decision Unit (CDU) with experience in Adult Congenital Heart Disease (ACHD) and over 10 years of experience in Emergency Medicine. She is also a Clinical Assistant Professor and Educator-4-Care (E4C) at the Stanford School of Medicine & Masters of Science in PA Studies Program.
-
Yusra Hussain, M.D.
Adjunct Clinical Assistant Professor, Medicine - Primary Care and Population Health
Current Research and Scholarly InterestsCollaborator in the HALF study
Collaborator in the PROMISE study
Primary Investigator, Bidet Pilot Study- 650-644-9230 -
Tridu Huynh
Clinical Assistant Professor, Medicine
Current Research and Scholarly InterestsMulti-Omics in Clonal Hematopoiesis of Indeterminate Potential
Undiagnosed Disease Network -
Elizabeth W Hwang
Clinical Associate Professor (Affiliated), Medicine - Med/Gastroenterology and Hepatology
Staff, Medicine - Med/Gastroenterology and HepatologyBioBOARD CERTIFICATIONS:
Transplant Hepatology
Gastroenterology
Internal Medicine
PROFESSIONAL EDUCATION:
Fellowship: Columbia University Medical Center, Transplant Hepatology
Fellowship: Stanford University School of Medicine, Gastroenterology and Hepatology
Residency: Columbia University Medical Center, Internal Medicine
Medical Education: Johns Hopkins University School of Medicine (2005) -
Joo Ha Hwang, MD, PhD
Fortinet Founders School of Medicine Professor and Professor, by courtesy, of Surgery
Current Research and Scholarly InterestsSpecialize in early detection of gastrointestinal malignancies including esophageal, gastric, pancreatic, bile duct & colon cancers. I have both a clinical & research interest in improving the early detection of gastric cancer in particular. I am the PI of the Gastric Precancerous conditions Study, a prospective study of patients with gastric intestinal metaplasia & other precancerous conditions which combines comprehensive clinical & endoscopic data with a large bio-specimen repository.
-
Stephanie Ibe
Research Program Coordinator NOURISH - Casual, Medicine - Primary Care and Population Health
Current Role at StanfordResearch Program Coordinator - NOURISH
-
David Iberri
Clinical Associate Professor, Medicine - Hematology
BioDr. Iberri is a hematologist who specializes in the treatment of multiple myeloma, Waldenström macroglobulinemia, and other blood and bone marrow disorders. He is actively involved in clinical research evaluating novel agents in hematologic malignancies. His research interests include the development and application of biomarkers to select patients most likely to benefit from therapy, and in the development of blood tests to reduce the need for bone marrow biopsies in myeloma disease monitoring.
-
Hirotaka Ieki
Postdoctoral Scholar, Cardiovascular Medicine
BioCardiologist in Japan.
Research interest: precision medicine in cardiovascular disease. Genomics, Exposomics. -
Gentaro Ikeda
Instructor, Medicine - Cardiovascular Medicine
BioDr. Ikeda is a physician-scientist who develops innovative diagnostic and therapeutic modalities for patients with cardiovascular disease. Based on his clinical experience as a cardiologist, he has become aware of major clinical shortcomings, specifically in the current pharmaceutical therapies for myocardial infarction (MI) and chronic heart failure (HF). Some evidence-based drug therapies, including β-blockers, ivabradine, and renin-angiotensin-aldosterone antagonists are difficult to apply to critical patients due to adverse side effects. Drugs that have shown efficacy in basic animal experiments have failed to show significant benefits in clinical trials. To address these problems, he moved to academia to conduct translational research. During his graduate training in the Egashira Lab, he focused on drug delivery systems (DDS) that target mitochondria in animal models of MI. He obtained advanced skills in molecular biology, mitochondrial bioenergetics, and animal surgery. He realized the importance of translational research and the great potential of DDS to overcome many clinical problems. He developed nanoparticle-mediated DDS containing cyclosporine for the treatment of patients with MI. He published a first-author paper and received academic awards for his novel science. Since becoming a postdoctoral fellow in the Yang Lab, he has continued to build upon his previous training in translational research. He is currently developing an innovative therapy, namely, extracellular vesicles-mediated mitochondrial transfer for mitochondria-related diseases such as heart failure and mitochondrial disease.
-
Fumiaki Ikeno
Program Director (U.S) Japan Biodesign, Stanford Biodesign, Medicine - Med/Cardiovascular Medicine
BioProgram Director (U.S) Japan Biodesign, Stanford Biodesign
Researcher Cardiovascular Medicine, Stanford University
Faculty of Japan Reach, CARE (Center for Asian Health Research and Education) , Stanford University
Co-Director of Asia, SPARK Global, Stanford SPARK , Stanford University
Dr. Ikeno is a Researcher, Cardiovascular Medicine, Stanford University. In this role, he is responsible for pre clinical studies including GLP for medical devices and also regenerative medicines for cardiovascular diseases. Currently, he is devoting himself to the international regulatory project between Japan and the United States, also known as "Harmonization by Doing", whose focus is to collaborate with regulatory agencies such as FDA, PMDA/MHLW, academia and industries for improving the regulatory process in the 2 largest medtech markets. Dr. Ikeno also devoted himself to found Japan biodesign program which is a collaborative program with University of Tokyo, Osaka University, Tohoku University, Japan Federation Medical Device Association, Ministry of Education Japan and Stanford biodesign program. Currently, Dr. Ikeno serves as the Program Director (US) for Japan Biodesign. Dr. Ikeno is co-founder and board member of US-Japan MedTech Frontier which is a non-profit cooperate to make a trans-pacific eco-system of medical device between Japan and USA.
After 9 years clinical practice as an interventional cardiologist and Family Doctor in rural areas of Japan, Dr. Ikeno came to Stanford as a Researcher and completed his Biodesign Certificate Program. Being part of the ecosystem in Silicon Valley, Dr. Ikeno participated in more than 200 medtech projects and 50 GLP studies as well as in the analysis of clinical trials for cardiovascular medicine (BARI2D, FAME, ReOPEN etc). His other academic consortium projects include Peripheral Academic Research Consortium, Global Consensus Working Group of Optical Coherence Tomography, and Japan-US consensus document for the treatment of critical limb ischemia.
Over the last decade, Dr. Ikeno has served as an advisor for medical device industries and currently serves as a chief medical officer of an incubation fund specific for medtech (Medventure Partners, Inc, Tokyo) as a spin-off from Innovation Network Corporation of Japan (INCJ) that is the largest government and private partnership fund in Japan. He is also serving as a chair of cardiovascular working group of APAN (Asian Pacific Advanced Network) that contributes the remote education, research activities, and tele-health using a specialized internet network. Dr.Ikeno is also serving as consulting faculty/lecturer roles in several universities in Japan including University of Tokyo, Osaka University, Tsukuba University etc. Dr. Ikeno has authored over 70 peer reviewed publications and textbooks and has been invited to lecture at international medical conferences. Dr. Ikeno is a council member of U.S.- Japan Council which is a non-profit organization by Japanese American. He is serving as a mentor for START-X MED which is an accelerating program for Stanford related entrepreneurs in medical fields.
Contact Information
Falk CVRC CV007
300 Pasteur Drive
Palo Alto, CA 94305-5406 -
Koto Imahori
Masters Student in Community Health and Prevention Research, admitted Autumn 2025
Stanford Student Employee, Bechtel International Center
Game Day Staff, Undergrad Housing Front DesksCurrent Research and Scholarly InterestsPreventive Medicine, Suicidology, Eating Disorders
-
John P.A. Ioannidis
Professor of Medicine (Stanford Prevention Research Center), of Epidemiology and Population Health and, by courtesy, of Biomedical Data Science
Current Research and Scholarly InterestsMeta-research
Evidence-based medicine
Clinical and molecular epidemiology
Human genome epidemiology
Research design
Reporting of research
Empirical evaluation of bias in research
Randomized trials
Statistical methods and modeling
Meta-analysis and large-scale evidence
Prognosis, predictive, personalized, precision medicine and health
Sociology of science -
Eric Ip
Clinical Professor, Medicine - Primary Care and Population Health
Current Research and Scholarly InterestsMy research interests include the use and abuse of anabolic steroids and other performance enhancing/cognitive enhancing drugs.
-
Haruka Itakura, MD, PhD
Assistant Professor of Medicine (Oncology)
BioDr. Haruka Itakura is an Assistant Professor of Medicine (Oncology) in the Stanford University School of Medicine, a data scientist, and a practicing breast medical oncologist at the Stanford Women’s Cancer Center. She is board-certified in Oncology, Clinical Informatics, Hematology, and Internal Medicine. Her research mission is to drive medical advances at the intersection of cancer and data science, applying state-of-the-art machine learning/artificial intelligence (AI) techniques to extract clinically actionable knowledge from heterogeneous multi-scale cancer data to improve patient outcomes. Her ongoing research to develop robust methodologies and apply cutting-edge techniques to analyze complex cancer big data was catapulted by an NIH K01 Career Development Award in Biomedical Big Data Science after obtaining a PhD in Biomedical Informatics at Stanford University. Her cancer research focuses on extracting radiomic (pixel-level quantitative imaging) features of tumors from medical imaging studies and applying machine learning frameworks, including radiogenomic approaches, for the integrative analysis of heterogeneous, multiomic (e.g., radiomic, genomic, transcriptomic) data to accelerate discoveries in cancer diagnostics and therapeutics. Her current projects include data science/AI-powered prediction modeling of survival, treatment response, cancer recurrence, and metastasis in different cancer subtypes; detection of occult invasive breast cancer; and identification of novel therapeutic targets. Her goal is to translate her research findings back to the clinical setting for the benefit of patients with difficult-to-treat cancers.
